Literature DB >> 9524052

Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats.

A K-Laflamme1, L Wu, S Foucart, J de Champlain.   

Abstract

Early investigations have suggested a relationship between hypertension and melatonin, a pineal hormone. The aims of this study were to evaluate the implication of the sympathetic nervous system in the acute effect of melatonin on blood pressure in conscious 12-week-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY), and to determine whether the hypotensive effect of melatonin is associated with alterations in pre- or postsynaptic mechanisms. Melatonin, 10 mg/kg, produced a sustained time-dependent decrease of mean arterial pressure only in SHR without changes in heart rate in both groups. Until 20 min after melatonin administration, plasma epinephrine (EPI) levels were reduced by about 60% in both groups, but norepinephrine (NE) levels were decreased only in SHR by about 30%. The nitroprusside-induced hypotension responses and the associated increases in heart rate were similar in both groups before or after administration of melatonin. Unexpectedly, the sympathetic reactivity to nitroprusside, evaluated by the increases in NE and EPI, was markedly enhanced after melatonin treatment in both WKY and SHR. The stimulation induced [3H]-norepinephrine release from isolated atria was not altered by melatonin in SHR. In cultured aortic vascular smooth muscle cells, the basal and phenylephrine induced inositol phosphate formations were greater in SHR, and the melatonin pretreatment dose dependently attenuated the phenylephrine responses in cells from both WKY and SHR. Therefore the hypotensive action of melatonin appears to be associated with an inhibition of basal sympathoadrenal tone and could also be mediated partly by the blockade of postsynaptic alpha1-adrenergic receptor-induced inositol phosphate formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524052     DOI: 10.1016/s0895-7061(97)00401-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  24 in total

1.  General anesthesia for surgery influences melatonin and cortisol levels.

Authors:  Edward Ram; Tali H Vishne; Talia Weinstein; Benzion Beilin; Zeev Dreznik
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

2.  The effects of melatonin on electrical field stimulation-evoked biphasic twitch responses in the ipsilateral and contralateral rat vasa deferentia after unilateral testicular torsion/detorsion.

Authors:  Süreyya Barun; Gülşen Ekingen; Ismail Mert Vural; Zafer Türkyilmaz; Can Başaklar; Nuri Kale; Zeynep Sevim Ercan; Yusuf Sarioğlu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-08       Impact factor: 3.000

3.  Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study.

Authors:  P Lusardi; E Piazza; R Fogari
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

4.  The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats.

Authors:  Engin Sahna; Hakan Parlakpinar; Feral Ozturk; Yilmaz Cigremis; Ahmet Acet
Journal:  Urol Res       Date:  2003-04-29

5.  Melatonin improves memory acquisition under stress independent of stress hormone release.

Authors:  Ulrike Rimmele; Maria Spillmann; Carmen Bärtschi; Oliver T Wolf; Cora S Weber; Ulrike Ehlert; Petra H Wirtz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

6.  Melatonin attenuates alpha-adrenergic-induced contractions by increasing the release of vasoactive intestinal peptide in isolated rat penile bulb.

Authors:  Ercument Olmez; Zehra Kurcer
Journal:  Urol Res       Date:  2003-07-03

7.  Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans.

Authors:  Chester A Ray
Journal:  J Physiol       Date:  2003-07-17       Impact factor: 5.182

8.  Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.

Authors:  Sayaka Ishigaki; Naro Ohashi; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Masafumi Ono; Yukitoshi Sakao; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2016-01-07       Impact factor: 2.801

9.  Urinary melatonin and risk of incident hypertension among young women.

Authors:  John P Forman; Gary C Curhan; Eva S Schernhammer
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

10.  Melatonin ameliorates intrarenal renin-angiotensin system in a 5/6 nephrectomy rat model.

Authors:  Sayaka Ishigaki; Naro Ohashi; Takashi Matsuyama; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Tomoyuki Fujikura; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2017-11-20       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.